ERNEST HAWK to Administration, Oral
This is a "connection" page, showing publications ERNEST HAWK has written about Administration, Oral.
Connection Strength
0.017
-
Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studies. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):201-7.
Score: 0.009
-
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res. 2000 Jan; 6(1):78-89.
Score: 0.008